RBx-5736

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameRBx-5736

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Hyperplasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRanbaxy Laboratories

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRanbaxy Laboratories

Active IndicationsN/A

Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A

Related LinksN/A